American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
American Journal of Medical Case Reports. 2015, 3(4), 95-97
DOI: 10.12691/ajmcr-3-4-2
Open AccessCase Report

A Case Report on Acute Lymphoblastic Leukemia in A 10 Days Old Neonate

Prahlad Neupane1, Prasanna Dahal2, , Birat Acharya3, Sagar raj pandey4 and Ramesh Gautam5

1Consultant Paediatrician (MD) Bijayapur Hospital, Dharan-10, Sunsari, Nepal

2Clinical Pharmacist (Msc, PharmD) Bijayapur Hospital, Dharan-10, Sunsari, Nepal

3Physician (MBBS) Bijayapur Hospital, Dharan-10, Sunsari, Nepal

4Consultant Pathologist (MD) Bijayapur Hospital, Dharan-10, Sunsari, Nepal

5lab technologist (BMLT), Bijayapur Hospital, Dharan-10, Sunsari, Nepal

Pub. Date: February 27, 2015

Cite this paper:
Prahlad Neupane, Prasanna Dahal, Birat Acharya, Sagar raj pandey and Ramesh Gautam. A Case Report on Acute Lymphoblastic Leukemia in A 10 Days Old Neonate. American Journal of Medical Case Reports. 2015; 3(4):95-97. doi: 10.12691/ajmcr-3-4-2


Although leukemia’s are the most common malignant disease seen in children, it occurs rarely in neonates. Only few cases of congenital leukemia have been reported in literature. We report here a rare case of congenital lymphoblastic leukemia in a 10 days old full term male neonate of normal home delivery who presented in the hospital with complaints of fast breathing and fever of 1 day duration. Initial clinical manifestation was that of Multi organ dysfunction syndrome due to late onset neonatal sepsis but was found to have acute leukemia on subsequent investigations.

Neonate Infants Acute lymphoblastic leukemia malignancy

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


Figure of 2


[1]  Biondi A, Cimino G, Pieters R, Pui H C. Biological and therapeutic aspects of infant leukemia. Blood. 2000 jul; 96 (1): 24-33.
[2]  Reaman G, Zeltzer P, Bleyer WA. Acute lymphoblastic leukemia in infants less than 1 year of age. A cumulative experience of the Children Cancer Study Group. J ClinOncol 1985; 3: 1513-1521.
[3]  Gurgey A, Yetgin S, Çetin M, Gumruk F, Tuncer M, TunçbilekE, Hiçsonmez G. Acute lymphoblastic leukemia in infants. The Turkish Journal of Pediatrics 2004; 46: 115-119.
[4]  Belson M, Kingsley B, Holmes A. Risk Factors for Acute Leukemia in Children: A Review. Environ Health Perspect 2007; 115: 138-145.
[5]  Emerenciano M, Koifman S, Pombo-de-Oliveira MS. Acute leukemia in early childhood. Braz J Med Biol Res 2007; 40 (6): 749-760.
[6]  Pui CH, Kane JR, Crist WM. Biology and treatment of infant leukemias. Leukemia 1995; 9: 762-769.
[7]  Sethi RS, Sethi A. Continental leukemia. Indian Pediatrics 2002; 39: 497-500.
[8]  Kotecha RS, Gottardo NG, Kees UR, Cole CH. The evolution of clinical trials for infant acute lymphoblastic leukemia. Blood Cancer Journal 2014; 4: 1-13.
[9]  Napper A D, Watson V G. Targeted Drug Discovery for Pediatric Leukemia. Front Oncol. 2013; 3: 170.
[10]  Lee sherick A B, Linger RMA, Gore L, Keating A K, Graham D K. Targeting paediatric acute lymphoblastic leukaemia: novel therapies currently in development. Br J Haematol. 2010 Nov; 151 (4): 295-311.
[11]  Ott CJ, Kopp N, Bird L, Paranal RM, Qi J, Bowman T, Rodig SJ, Kung AL, Bradner JE, Weinstock DM. BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia. Blood. 2012 Oct 4; 120 (14): 2843-52.